Searchable abstracts of presentations at key conferences in endocrinology

ea0066p71 | Learning from Mistakes and Miscellaneous | BSPED2019

Intracranial hypertension secondary to severe obesity: case series

Apperley Louise , Erlandson-Parry Karen , Laing Peter , Das Urmi , Senniappan Senthil

Introduction: The prevalence of childhood obesity is continuing to increase, especially in more deprived areas. It is estimated that 28% of children are overweight or obese in England. Evidence has shown that obesity is associated with increased intracranial pressure (ICP) in adult and paediatric populations. We report three patients who presented with intracranial hypertension due to severe obesity.Case 1: A fifteen-year-old girl presented with severe h...

ea0063p299 | Reproductive Endocrinology 1 | ECE2019

High prevalence of psychopathologies among transgender patients presenting at a large tertiary center: implication for the treating clinicians

Kerem Gil , Greenman Yona , Yaish Iris , Sofer Yael , Stern Naftali , Tordjman Karen

Background and aim of study: Endocrinologists play a central role in the gender affirming process that transgender people chose to undergo, and may be ill-prepared to recognize and manage psychologic difficulties that accompany gender dysphoria. We sought to characterize the patient population currently under our care with respect to their mental health, and to address the question of possible differences between transwomen (TW) and transmen (TM).Methods...

ea0049ep1313 | Thyroid (non-cancer) | ECE2017

Management of relapsing Graves: a clinical survey among endocrinologists in Israel

Koren Shlomit , Shteinshnaider Miriam , Or Karen , Cantrell Dror , Benbassat Carlos A , Koren Ronit

Background: The management of relapsing Graves’ disease is controversial. Previous surveys from different regions in the world demonstrated variations in the clinical practices of patients with Graves’ disease relapse.Methods: To determine management pattern among endocrinologists in Israel an electronic questionnaire was e-mailed to all members of the Israeli Endocrine Society. Questionnaires included demographic data and clinical scenarios wi...

ea0044p7 | Adrenal and Steroids | SFEBES2016

Screening for Cushings syndrome: A comparison of available tests

McKeever Edward , McCance David R , Hunter Steven J , Courtney Hamish , Mullan Karen R , Graham Una M

Nocturnal salivary cortisol (NSC), urinary free cortisol (UFC) and overnight dexamethasone suppression testing (ODS) are recommended screening tests for Cushing’s syndrome (CS). Individual centers differ in their screening approach; UFC being the test of choice in Northern Ireland with ODS in patients with adrenal incidentalomas. NSC, which measures free cortisol, is not routinely used. The aims of this study were to 1. Evaluate the utility of NSC in the diagnosis of CS; ...

ea0044p165 | Neuroendocrinology and pituitary | SFEBES2016

Olfactory neuroblastoma: a multi centre clinical and pathological review

Young Karen , Orban Nara , Clarke Peter , Sandison Ann , Gilkes Catherine , Alusi Ghassan , Korbonits Marta

Olfactory neuroblastoma (ONB) is a rare neuroendocrine tumour arising within the sino-nasal cavity. It occurs world wide, affecting both sexes, all ages and all races with no underlying predilection having yet been identified. ONB exhibits a range of phenotypes from indolent to very aggressive, and up to 5% cases are associated with ectopic hormone secretion. Despite current gold-standard treatment of surgical resection (either endoscopic or craniofacial resection) followed by...

ea0041ep937 | Pituitary - Clinical | ECE2016

Trial design of a phase III, multicentre, randomised, double-blind, placebo-controlled, 48-week study to evaluate the safety and efficacy of osilodrostat in patients with Cushing’s disease

Feelders Richard A , Heaney Anthony , McBride Karen , Hilliard Annie , Tian Chuan , Sauter Nicholas , Auchus Richard J

Background: Osilodrostat is an oral inhibitor of 11β-hydroxylase (CYP11B1), the enzyme that catalyses the final step in cortisol biosynthesis. In a 22-week, phase II study, osilodrostat treatment normalised mean urinary free cortisol (mUFC) in 78.9% (15/19) of patients with uncontrolled Cushing’s disease and was well tolerated. The present phase 3 study is designed to confirm the safety and efficacy of osilodrostat in patients with uncontrolled Cushing’s disease...

ea0039ep29 | Diabetes | BSPED2015

Factors influencing type 1 diabetes control in children – a detailed local analysis of an NPDA dataset

Fang Clarissa , Trewella Emily , Aminu Kingi , Spowart Karen , Bridges Nicola , Alexander Saji

Background: National paediatric diabetes audit (NPDA) provides comparative data for local paediatric diabetes units (PDUs) on key care processes and overall HbA1c. More detailed analysis on other variables affecting HbA1c is undertaken at a national level, but not at an individual PDU level.Objective: To determine the factors influencing glycaemic control (HbA1c levels) in young children and adolescents with Type 1 Diabetes Mellitus (T1DM).<p class="...

ea0059p018 | Adrenal and steroids | SFEBES2018

The role of plasma metanephrines and plasma catecholamines in the biochemical testing for Pheochromocytoma

Spence Kirsty , Hunter Steven , Brown Campbell , Thompson Paul , Mullan Karen , McDonnell Margaret

First line screening for pheochromocytoma, as recommend by Endocrine Society guidelines, is to determine plasma free or urinary fractionated metanephrines. We routinely offer the latter. Although negative results rule out pheochromocytoma, it is not uncommon to see borderline results which require further investigation. In this situation we have historically relied on the measurement of plasma catecholamines in the clonidine suppression test (CST). Plasma metanephrines, howeve...

ea0059p021 | Adrenal and steroids | SFEBES2018

Does a 60 minute sample in addition to a 30 minute sample for cortisol in the Short Synacthen Test alter patient management?

Campbell Karen , Galloway Iona , Grant Donna , Smith Frances , Tough Jillian , Freel E Marie

Aim: The short Synacthen test (SST) is an established test used to assess the hypothalamic-pituitary-adrenal axis. There remains debate whether a 30 minute or 60 minute cortisol sample has diagnostic superiority. Currently at the Queen Elizabeth University Hospital, Glasgow all tests arranged by endocrinology are performed by endocrine nurse specialists who utilise a 0 and 30 minute cortisol protocol. Performing a further 60 minute sample requires more nursing time and space r...

ea0038fp3 | (1) | SFEBES2015

Maternal genotype is an important determinant of the outcome of antenatal glucocorticoid treatment in GR+/+ and GR+/− foetal mice

Batchen Emma , Richardson Rachel , Thomson Adrian , Moran Carmel , Gray Gillian , Chapman Karen

Glucocorticoids are routinely administered to pregnant women at risk of pre-term delivery to mature foetal organs and improve neonatal survival. Previous work in glucocorticoid receptor (GR)-deficient mice showed that GR activation is essential for maturation of the foetal heart. Here, we tested the hypotheses that i) antenatal glucocorticoid exposure, prior to the normal increase in glucocorticoid levels, will advance foetal heart maturation and ii) this would depend on mater...